Objective To evaluate genetic disease among children referred to a community paediatric clinic.
Design Retrospective cohort study.
Setting Community paediatric clinic, Tower Hamlets, London.
Patients All patients seen for first time in the Child Development Team (CDT) clinic between 1999 and 2013.
Interventions Clinical notes were reviewed. Genetic test results were obtained. Exploratory Excel analysis was performed. Patients without an identified genetic disorder were labelled ‘more likely genetic cause’ if they had at least two out of three risk factors: developmental delay, congenital abnormality or parental consanguinity, and ‘unlikely genetic cause’ if they had one or no risk factors, or an obvious alternative cause.
Main outcome measures Prevalence of genetic diagnoses and parental consanguinity, undertaking of genetic tests, predicted likelihood of a genetic cause among unsolved patients.
Results 749 patients were included. 404 (53.9%) had undergone genetic testing and 158 of those tested (39.1%) had a confirmed genetic diagnosis. Parental relatedness was documented in 461 patients, of which 128 (27.8%) had first-cousin parents. The number of patients undergoing genetic testing increased over time. Aneuploidies and syndromic/Mendelian disorders were most common. Of the 591 patients without a genetic diagnosis, 29.9% were classified ‘more likely genetic cause’. Patients with consanguineous parents were significantly more likely to have a diagnosed genetic disorder than those with non-consanguineous parents (43/128 vs 72/333), particularly an autosomal recessive condition (27/43 vs 6/72).
Conclusions Genetic disease was common and genetic testing is important in evaluating children in this clinic. Consanguinity increases the likelihood of autosomal recessive disease.
- Comm Child Health
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Contributors SB, ER and MB all made substantial contributions to the conception and design of the study. MB provided the database, and data collection was performed by SB. All three authors were involved in data analysis and interpretation. SB drafted the original manuscript, which was revised with the help of ER and MB. All authors provided final approval of this version to be published and all agree to be accountable for all aspects of the work.
Competing interests None declared.
Provenance and peer review Not commissioned; externally peer reviewed.
Data sharing statement The individual variants identified in all patients are not published. This includes the point mutations in the monogenic and metabolic disorders, and the specific chromosomal abnormalities. This information is accessible to the clinical care teams at the Wellington Way Centre and the Clinical Genetics Department at Great Ormond Street Hospital. These are saved on secure systems within each trust and are password protected.